Prestige Consumer (PBH) Director Celeste Clark Receives Award

What Happened
Celeste A. Clark, a director of Prestige Consumer Healthcare, was granted 2,981 restricted stock units (RSUs) on August 4, 2026. The RSUs were valued at $155,000 based on the $52.00 closing price that day. No cash was paid now — this is a compensation award, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-08-04 (reported on Form 4 filed 2026-08-05)
• Transaction type/code: Award (A) — 2,981 RSUs @ $0.00 reported price
• Grant value: $155,000 (2,981 RSUs × $52.00 closing price)
• Vesting/settlement: RSUs vest on the first anniversary of the grant and will be settled by delivery of one share of common stock per vested RSU promptly following the earliest of (1) the reporting person's death, (2) separation, or (3) change in control (per filing footnote).
• Shares owned after transaction: Not specified in the filing.
• Filing timeliness: Filed the next day (appears timely). No 10b5-1 or tax-withholding details disclosed.

Context
RSUs are a form of compensation that convert to actual shares only upon vesting (or earlier in certain events noted above). Director RSU grants are common and reflect compensation, not an indication of immediate buying or selling sentiment.